Donaldson Company DCI Life Sciences Segment — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Donaldson Company in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Donaldson Company’s 10-Q, filed June 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Donaldson Company's life sciences segment — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Donaldson Company's life sciences segment — cost of sales?
- Donaldson Company (DCI) reported life sciences segment — cost of sales of $49.2M in Q1 2026.
- How has Donaldson Company's life sciences segment — cost of sales changed year-over-year?
- Donaldson Company's life sciences segment — cost of sales increased by 7.9% year-over-year, from $45.6M to $49.2M.
- What is the long-term trend for Donaldson Company's life sciences segment — cost of sales?
- Over 2 years (2023 to 2025), Donaldson Company's life sciences segment — cost of sales has grown at a 14.1% compound annual growth rate (CAGR), from $136.8M to $178.1M.
- What does life sciences segment — cost of sales mean?
- The direct costs incurred to manufacture and deliver products sold by the Life Sciences segment.
- How do you interpret life sciences segment — cost of sales?
- Lower costs relative to sales indicate improved manufacturing efficiency or better supply chain management.
- How does life sciences segment — cost of sales compare across companies?
- Peers in high-precision manufacturing should maintain consistent cost-to-sales ratios; deviations suggest production inefficiencies.